Table 1.
Demographic and clinical data from human subjects.
| Control (n = 29) | STEMI (n = 28) | P-value | |
|---|---|---|---|
| Age, years | 64 (53–67) | 65 (57–73) | 0.506 |
| Female | 11 (37.9) | 5 (17.9) | 0.092 |
| Ethnicity—White | 29 (100) | 28 (100) | >0.999 |
| Height, cm | 167.8 ± 8.5 | 168.0 ± 6.7 | 0.947 |
| Weight, kg | 80.0 (73.0–87.5) | 77.5 (70.0–88.5) | 0.856 |
| BMI, kg/m−2 | 28.4 (27.2–30.1) | 28.3 (25.6–29.6) | 0.854 |
| CV risk | |||
| Type 2 diabetes mellitus | 7 (24.1) | 6 (21.4) | 0.808 |
| Arterial hypertension | 24 (82.8) | 15 (53.6) | 0.018a |
| Dyslipidemia | 24 (82.8) | 18 (64.3) | 0.113 |
| Active smoker | 10 (34.5) | 15 (53.6) | 0.147 |
| Previous CAD | 0 (0) | 5 (17.9) | 0.017a |
| Chronic kidney disease | 0 (0) | 5 (17.9) | 0.017a |
| CCU admission | |||
| Troponin I, ng/ml | N/a | 25.8 (4.2–54.9) | — |
| Peak troponin I, ng/ml | N/a | 65.0 (24–117.0) | — |
| NT-proBNP, pg/ml | N/a | 488.5 (180.8–1,642.0) | — |
| C-reactive protein, mg/dl | N/a | 1.1 (0.3–2.9) | — |
| Serum creatinine, mg/dl | N/a | 0.9 (0.8–1.3) | — |
| Hemoglobin, g/dl | N/a | 13.44 ± 2.03 | — |
Values are median (interquartile range), n (%) or mean ± SD; BMI, body mass index; CV, cardiovascular; CAD, coronary artery disease; CCU, coronary care unit; NT-proBNP, N-terminal prohormone of brain natriuretic peptide; N/a, non-applicable.
a
Adjusted P-value < 0.05.